Covid vaccine: Glenmark’s phase-3 clinical trial of Favipiravir shows positive response https://ift.tt/eA8V8J

July 23, 2020 at 06:00AM
Favipiravir is a broad spectrum oral antiviral drug that selectively inhibits RNA-dependent RNA polymerase (RdRp) and the viral replication phase of SARS-CoV-2, and is being studied in multiple ongoing international clinical trials.

from The Financial Express